Binningen, Switzerland

Paulo G Santos


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Paulo G Santos in Pharmaceutical Formulations

Introduction

Paulo G Santos is a notable inventor based in Binningen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in developing formulations that address serious respiratory conditions. His work is characterized by a commitment to improving patient outcomes through innovative solutions.

Latest Patents

Paulo G Santos holds a patent for a formulation titled "Formulations of (S)-3-amino-6-methoxy-N-(3,3,3-trifluoro-2-hydroxy-2-methylpropyl)-5-(trifluoromethyl)picolinamide." This patent describes compounds and pharmaceutical compositions that are useful for treating bronchiectasis, chronic obstructive pulmonary disorder, cystic fibrosis, chronic bronchitis, or asthma. The formulations aim to provide a therapeutically effective amount of the compound to subjects in need.

Career Highlights

Santos is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to work on groundbreaking research and development projects that focus on innovative therapeutic solutions. His expertise in pharmaceutical formulations has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Paulo has collaborated with talented professionals, including Vivek Dubey and Rohit Lowalekar. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Paulo G Santos exemplifies the spirit of innovation in the pharmaceutical industry through his patent and contributions to respiratory health. His work continues to impact the lives of patients suffering from chronic respiratory conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…